<strong>Mark</strong> E. <strong>Dunlap</strong>, <strong>MD</strong>Curriculum Vitae, page 2069. Mack S, Smith R, <strong>Dunlap</strong> ME: Systematic Heart Failure Education Improves Patient Self-Care <strong>and</strong> Self-Efficacy. J Cardiac Failure, 15(6) 349, 2009.70. Jurcevic D, Siddiqi N, <strong>Dunlap</strong> ME, Krishnan V: Polysomnographic Differences in Patients with SystolicDysfunction Versus Preserved Ejection Fraction Heart Failure. ATS A3674, 2010.71. Razavi A, Mack S, <strong>Dunlap</strong> ME, Krishnan V: Prospectve Evaluation Of Sleep Disorders In Preserved EjectionFraction Heart Failure Patients. Sleep 33:A299 2010.72. Siddiqi N, Jurcevic D, Krishnan V, <strong>Dunlap</strong> ME: Sleep Apnea Is Highly Prevalent in Patients Hospitalized forHeart Failure With Preserved Ejection Fraction. Journal <strong>of</strong> Cardiac Failure 16(8):S116, 2010.73. Ginwalla M, Rader F, Pasala T, Johnson J, <strong>Dunlap</strong> ME: Pulse Pressure Widening Is a Determinant <strong>of</strong>Diastolic Dysfunction. Journal <strong>of</strong> Cardiac Failure 2011.74. Cevasco M, Sullivan K, <strong>Dunlap</strong> ME: Optimal Heart Failure Management in the Outpatient Setting:Assessing Treatment by Provider Type. Journal <strong>of</strong> Cardiac Failure 2011.75. Khan I, Anna K, <strong>Dunlap</strong> ME: Vaccination rates in heart failure at an academic medical center: Are wemissing the target? Journal <strong>of</strong> Cardiac Failure 2011.76. Li Y, Whellan DJ, <strong>Dunlap</strong> ME, Kraus WE, Samsa G, Schulman KA, Zile M, Reed SD. Resource Use <strong>and</strong>Medical Costs by Cause <strong>of</strong> Death in HF-ACTION. Journal <strong>of</strong> Cardiac Failure 2011.77. Metra M, Hern<strong>and</strong>ez AF, Heizer GM, Clausell N, Corbalan R, Costanzo MR, <strong>Dunlap</strong> ME, Ezekowitz JA,Howlett JG, Krum H, Voors AA, Armstrong PW, Massie BM, Dickstein K, Nieminen MS, Komajda M,McMurray JJV, Swedberg K, Starling RC, O'Connor CM, Califf RM, Teerlink JR: Geographic Variation inClinical Course Among Patients Hospitalized for Acute Heart Failure: Insights from ASCEND-HF. Circulation2011.78. Forman DE, Fleg J, Kitzman D, Brawner C, Swank A, McKelvie R, Clare R, Ellis S, <strong>Dunlap</strong> M, Bittner V:Does the 6 Minute Walk Test Provide Useful Prognostic Information in Systolic Heart Failure Patients?Circulation 2011.79. Krum H, Schlaich M, Sobotka P, Esler M, Mahfoud F, Böhm M, <strong>Dunlap</strong> M, Rocha-Singh K, Katholi R: LongtermFollow-up <strong>of</strong> Catheter-based Renal Denervation For Resistant Hypertension Confirms Durable BloodPressure Reduction TCT 2012.11) Scientific <strong>and</strong> Educational PresentationsNovember 1989November 1991June 1992November 1992November 1993March 1995September 1995Chairman, Session on Reflex Control in Heart Failure62nd Scientific Sessions <strong>of</strong> the American Heart AssociationChairman, Session on Baroreflex Mechanisms in Normal <strong>and</strong> Disease States64th Scientific Sessions <strong>of</strong> the American Heart Association9th Annual Health Science Association Cardiovascular Research ConferenceYoung Investigators Symposium, West Point, PennsylvaniaChairman, Session on Baroreceptors <strong>and</strong> Baroreflexes65th Scientific Sessions <strong>of</strong> the American Heart AssociationChairman, Session on Autonomic/Reflex Control: Heart Failure <strong>and</strong> Exercise66th Scientific Sessions <strong>of</strong> the American Heart Association"Neurohumoral Mechanisms <strong>of</strong> Heart Failure: Potential Utility <strong>of</strong> Angiotensin II Antagonists";Symposium on New Therapeutic Agents in the Management <strong>of</strong> Hypertension <strong>and</strong> HeartFailure: Angiotensin II Receptor Antagonists, Division <strong>of</strong> HypertensionCase Western Reserve University, Clevel<strong>and</strong>, OHCSF Levels <strong>of</strong> Angiotensin-II Are Decreased in Congestive Heart Failure
<strong>Mark</strong> E. <strong>Dunlap</strong>, <strong>MD</strong>Curriculum Vitae, page 21March 1996April 1996May 1996September 1996January 1998April 1998May 1998November 1998November 1998April 1999August 1999January 2000January 2000February 2000June 2000September 2000November 2000December 2000March 2001June 2001June 2001July 2001American College <strong>of</strong> Cardiology, Ohio Chapter"Baroreflex in Heart Failure"; Neurohormones in Heart Failure Expert PanelOrl<strong>and</strong>o, Florida (sponsored by Medtronic, Inc.)Chairman, Session on Neural Control <strong>of</strong> Circulation;Experimental Biology meeting, Washington, DC"Neuroexcitatory State <strong>and</strong> Disease Progression in Congestive Heart Failure"Symposium on Exercise in Congestive Heart FailureAmerican College <strong>of</strong> Sports Medicine, Cincinnati, OhioSpecial invitation to speak at XXIII Argentine Congress <strong>of</strong> CardiologyBuenos Aires, Argentina“Challenges <strong>and</strong> Progress in Managing Hypertension”, Detroit, MichiganInvited presentation, Research Day, Clevel<strong>and</strong> VAMC:“Congestive Heart Failure: From Leaves to Snake Venom <strong>and</strong> Beyond”Invited presentation, “Abnormalities <strong>of</strong> Autonomic Control in Heart Failure”, Second AnnualRetreat <strong>of</strong> the Cardiac Bioelectricity Research <strong>and</strong> Training Center, CWRUChairman, Session on Mechanisms <strong>of</strong> Autonomic Control in Heart Failure71st Scientific Sessions <strong>of</strong> the American Heart Association“Cholinergic control in heart failure”Clevel<strong>and</strong> Clinic Foundation Anesthesia Gr<strong>and</strong> Rounds“Nocturnal Hypoxemia: Congestive Heart Failure or Sleep Apnea?”Invited speaker, conference on Cardio-Pulmonary Evaluation <strong>and</strong> Management in ClinicalPractice, sponsored by University Hospitals <strong>of</strong> Clevel<strong>and</strong> <strong>and</strong> CWRU“Role <strong>of</strong> Ganglionic Transmission in Parasympathetic Abnormalities in Heart Failure”The Pascal Goldschmidt Invited Speaker,The Ohio State University Medical Center, Heart <strong>and</strong> Lung Institute, Columbus, OH“Issues <strong>of</strong> Aspirin <strong>and</strong> ACE Inhibition Use”PEACE investigators’ meeting, Palm Harbor, Florida“Strategies for Increasing Patient Enrollment”PEACE investigators’ meeting, Palm Harbor, Florida“Cholinergic Mechanisms in Heart Failure”Howard University, <strong>Department</strong> <strong>of</strong> Pharmacology, Washington DCInvited Speaker <strong>and</strong> Visiting Pr<strong>of</strong>essor, “Abnormalities <strong>of</strong> Cholinergic Control in HeartFailure”, University <strong>of</strong> Toronto, Toronto, Ontario, CanadaUS Representative, CHARM Steering Committee Meeting, Amsterdam, The Netherl<strong>and</strong>sChairman, Session on Autonomic Cardiovascular Control: Basic Nitric Oxide <strong>and</strong> NatriureticPeptide Mechanisms, 73rd Scientific Sessions <strong>of</strong> the American Heart Association“Abnormalities <strong>of</strong> Sympathetic <strong>and</strong> Parasympathetic Control in Heart Failure”; Peter BentBrigham Hospital Cardiology Gr<strong>and</strong> Rounds, Harvard University, Boston, Mass.“ARB’s vs. ACEI’s vs. Beta Blockers: Which Treatment for Heart Failure?”Symposium on CV Disease: The Promise <strong>of</strong> Prevention <strong>and</strong> Reversal <strong>of</strong> Target OrganDamage, Palm Springs, California“Recruitment <strong>and</strong> Retention in the PEACE trial”, panel discussionPEACE investigators meeting, San Antonio, Texas“Mechanisms <strong>of</strong> Baroreflex Abnormalities in Heart Failure”Simposio Internacional de Salud, Rosario, Argentina“Strategies to Optimize the Clinical Care <strong>of</strong> the Heart Failure Patient”
- Page 1 and 2: CURRICULUM VITAEMark Evans Dunlap,
- Page 3 and 4: Mark E. Dunlap, MDCurriculum Vitae,
- Page 5: Mark E. Dunlap, MDCurriculum Vitae,
- Page 9 and 10: Mark E. Dunlap, MDCurriculum Vitae,
- Page 11: Mark E. Dunlap, MDCurriculum Vitae,
- Page 14 and 15: Mark E. Dunlap, MDCurriculum Vitae,
- Page 16 and 17: Mark E. Dunlap, MDCurriculum Vitae,
- Page 18 and 19: Mark E. Dunlap, MDCurriculum Vitae,
- Page 22 and 23: Mark E. Dunlap, MDCurriculum Vitae,
- Page 24 and 25: Mark E. Dunlap, MDCurriculum Vitae,
- Page 26 and 27: Mark E. Dunlap, MDCurriculum Vitae,
- Page 28 and 29: Mark E. Dunlap, MDCurriculum Vitae,
- Page 30 and 31: Mark E. Dunlap, MDCurriculum Vitae,
- Page 32: Mark E. Dunlap, MDCurriculum Vitae,